Proudly sponsored by
| Session | Abstract title | Category | Author | |
|---|---|---|---|---|
| O-1 | Choosing the Right Path: Electrophilic vs Nucleophilic Radiobromination |
Other Halogen Radionuclide Chemistry | Shelbie Cingoranelli | View |
| O-2 | Machine Learning-Guided Investigation of Electrophilic and Nucleophilic [77Br]Br Radiobromination Reactions |
Other Halogen Radionuclide Chemistry | Samantha Boisvert | View |
| O-3 | Development of 211At-Labeled FAP Radiotheranostics: Aromatic Radioastatination and Stabilization Strategies for Targeted Alpha Therapy |
Other Halogen Radionuclide Chemistry | Sarandeep Kaur | View |
| O-4 | Separation of 211At with the use of functionalized gold nanoparticles (AuNPs) |
Other Halogen Radionuclide Chemistry | Shayden Fritz | View |
| O-5 | The Exploration of Halogen Chemistry on Buckyballs for Understanding Homologues of 211Astatine |
Other Halogen Radionuclide Chemistry | Elizabeth Schnorrenberg | View |
| O-6 | Development of a New Glutamate Based Glioblastoma Targeting Radiotheranostic Agent |
Halogen-based Theranostics | Yngve Guttormsen | View |
| O-7 | ALK2-Targeted PET Radiotracers to Support Drug Development in Diffuse Intrinsic Pontine Glioma |
Radiopharmaceuticals for Oncology | Amanda Gollinger | View |
| O-8 | Automated radiosynthesis and in vitro transport mechanisms of amino acid PET radiotracers for triple-negative breast cancer imaging |
Radiopharmaceuticals for Oncology | Piyasuda Pukkanast | View |
| O-9 | Comparison of Random and Site-Specific Radiohalogenation of GPC3-targeted Single Domain Antibody Fragments for Optimizing Targeted Radiotherapeutics |
Radiopharmaceuticals for Oncology | Gwyn Lai | View |
| O-10 | Stereoselective Synthesis and Evaluation of [¹⁸F] (2S,4R)-4- and (2S,4S)-4-Fluoroglutamine PET Tracers for Imaging Glutaminolysis in Triple-Negative Breast Cancer |
Radiopharmaceuticals for Oncology | Manikandan Palani | View |
| O-11 | First-in-human studies of SOAT1 targeted PET radioligand for imaging cholesterol metabolism in overactive adrenal glands |
Radiopharmaceuticals for Other Indications | Gina Kaup | View |
| O-12 | Radiosynthesis of [11C]CN-VJDT for imaging TREM1-positive myeloid cells in the brain and beyond. |
Carbon-11 Chemistry | Jun Hyung Park | View |
| O-13 | PET Imaging of (R)- and (S)-[11C]Nicotine Reveals Stereoselective Brain Pharmacokinetics |
Carbon-11 Chemistry | Ryan Fitzgerald | View |
| O-14 | Synthesis of Aryl [11C]-Ketones via In-Loop 11C-Carbonylation Using GE Tracerlab FX Synthesis Modules |
Carbon-11 Chemistry | Tanpreet Kaur | View |
| O-15 | Synthesis of [11C]18A-Me for PET Imaging of 4R tau |
Carbon-11 Chemistry | Martynas Širvinskas | View |
| O-16 | Radiosyntheses of [11C]Carfentanil and [11C]NOP-1A for in-human Opioid Receptor PET Imaging |
Carbon-11 Chemistry | Enci Ding | View |
| O-17 | Built-In Carbon-14: Nanoplastic Radiotracers for Chronic Airway Exposure |
Other Organic Radionuclide Chemistry | Olga Khaybullina | View |
| O-18 | Development and Optimization of an Automated Method for the Synthesis of [18F]Fluoroedaravone on a Trasis AllinOne Radiosynthesizer. |
Fluorine-18 Chemistry | arijit ghosh | View |
| O-19 | Investigation of conditions for oxidation of radiolabelled inverse electron demand Diels-Alder reaction intermediate products |
Fluorine-18 Chemistry | Dominika Novotná | View |
| O-20 | High-Throughput Exploration of Functional Group Tolerance of Sulfonium Salts for Radiofluorination |
Fluorine-18 Chemistry | Shagana MURUGANANTHAM | View |
| O-21 | Iron-Catalyzed Aminoradiofluroination of Monofluorinated Alkenes to ß,ß-Radiodifluoroamines |
Fluorine-18 Chemistry | Hannah Le | View |
| O-22 | Efficient radiosynthesis of [18F]FSK via a thermostable nigerose phosphoryalse |
Fluorine-18 Chemistry | Jung Min Kim | View |
| O-23 | Managing radioactive wastes from a 18F-radiotracer production facility |
Fluorine-18 Chemistry | Sylvestre Dammicco | View |
| O-24 | cGMP-ready automated production of [18F]SMBT-1 for the early diagnosis of Alzheimer's Disease |
Fluorine-18 Chemistry | Rhizlane kribii | View |
| O-25 | Design of a General Single-Step Radiofluorination Cassette for Automated cGMP-compliant PET Radiotracer Synthesis: Validation using [18F]SynVesT-1 |
Fluorine-18 Chemistry | RAMYA TOKALA | View |
| O-26 | Optimization of Experimental Buffer Parameters for [18F]BCPP-EF Autoradiography in Mitochondrial Complex I Imaging |
Radiopharmaceuticals for Neurology | Adrienne Winterhelt | View |
| O-27 | PET imaging of Cranial Radiotherapy induced Neuroinflammatory sequelae: [18F]4FN vs 18F-PBR06 |
Radiopharmaceuticals for Neurology | Preeti Jha | View |
| O-28 | [18F]SMBT-1 Autoradiography for Assessing Regional MAO-B-defined Reactive Astrogliosis in Neurodegenerative Diseases |
Radiopharmaceuticals for Neurology | Seresa McDowell | View |
| P-1 | Radiosynthesis of Calcitonin Calcitonin Gene-Related Peptide Receptor (CGRP) imaging Radioligand [11C]MK4232, through In-loop Chemistry |
Carbon-11 Chemistry | Tanpreet Kaur | View |
| P-2 | Optimized Manufacturing of [18F]DPA‑714: A GMP‑Ready Process for Clinical TSPO‑PET |
Fluorine-18 Chemistry | Alexandre HUMBLOT-NEGRI | View |
| P-3 | Optimization of Precursor/Standard Synthesis and Platform Migration for the Automated Radiosynthesis of (R)-[18F]MeFAMP |
Fluorine-18 Chemistry | TIANYU HUANG | View |
| P-4 | Radiolabeling of Vorasidenib with Fluorine-18 for Imaging IDH Mutation in Gliomas |
Fluorine-18 Chemistry | Xuan Fu | View |
| P-5 | Facile O-glycosidation of [18F]FDG for the radiosynthesis of 18F-glucosides |
Fluorine-18 Chemistry | Sanghee Lee | View |
| P-6 | High Molar Activity [131I]iodophenylalanine via DoE Optimization of Radioiododeborylation |
Other Halogen Radionuclide Chemistry | Yngve Guttormsen | View |
| P-7 | An easy and effective approach to synthesize [14C]menthol via in situ hydrogenation of thymol under atmospheric pressure |
Other Organic Radionuclide Chemistry | Md Juwel Hosen | View |
| P-8 | A Method to Radiolabel Antisense Oligonucleotides with Gallium-68 to Enable Biodistribution Studies |
Other Organic Radionuclide Chemistry | Helen SaTsu | View |
| P-9 | Rapid access towards MAO-B radiotracers from palladium-catalyzed cross-coupling reactions |
Radiopharmaceuticals for Neurology | Brian Valladares | View |
| P-10 | Development of Radiolabeled Amonafide Derivatives as A GSH-Responsive PET ligand |
Radiopharmaceuticals for Oncology | Nayeong Hwang | View |
| P-11 | Novel PSMA ligands for enhanced 177Lu radiolabeling efficiency, molar activity capacity and biological performance |
Radiopharmaceuticals for Oncology | Paulína Pažítková | View |
| P-12 | Scaling Up Ac-225 Production from the Ra-226(p,2n)Ac-225 Reaction: Can we Automate the Separation of Actinium-225 from Radium-226 Using a Commercial Radiochemistry Module? |
Radiopharmaceuticals for Oncology | Alexander Yordanov | View |
| P-13 | Breaking Barriers: Tight Junction-Directed Radiotheranostic Probes for Metastatic Colorectal Cancer |
Radiopharmaceuticals for Oncology | Ha Tran | View |
| P-14 | Molecular Dynamics Simulation-Based Evaluation of the 5O5T–Compound 3c Complex in Radioligand Therapy (ATX-101) for Structural Stability and Binding Robustness |
Radiopharmaceuticals for Oncology | Punna Rao Suryadevara Suryadevara | View |
| P-15 | Therapeutic Synergy of a MUC13-Targeted Radiopharmaceutical and ATR Inhibition in Colorectal Cancer |
Radiopharmaceuticals for Oncology | Ying Chen | View |